This inventor holds 1 USPTO granted patent. Top assignee: J2h Biotech Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Yeon-Woo Son: Innovator in Pharmaceutical Composition
Introduction
Yeon-Woo Son is a notable inventor based in Hwaseong-Si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of liver diseases. His innovative work has led to the development of a unique medical composition aimed at addressing non-alcoholic steatohepatitis.
Latest Patents
Yeon-Woo Son holds one patent for a pharmaceutical composition designed for preventing or treating non-alcoholic steatohepatitis (NASH) and hepatic fibrosis. This invention relates to the medical use of a compound, identified by Chemical Formula 1, which has shown promise in alleviating the symptoms associated with these liver conditions.
Career Highlights
Son is currently associated with J2H Biotech Inc., where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions in biotechnology, particularly in the realm of liver health.
Collaborations
Some of his notable coworkers include Jae-Sun Kim and Hyung-Chul Ryu, who contribute to the collaborative efforts at J2H Biotech Inc. Their combined expertise enhances the research environment and fosters innovation within the company.
Conclusion
Yeon-Woo Son's contributions to pharmaceutical innovation, particularly in the treatment of liver diseases, highlight his role as a key inventor in the field. His patent for a composition targeting non-alcoholic steatohepatitis showcases his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile